Show Product List
- Bifilac Clausi
- Bifilac Activ
- Bifilac Capsules
- BIFILAC Dry Syrup
- Bifilac Sachet
- Bifilac HP Capsules
- Bifilac GG
- Sporit GG 10bn
- Bifilac GG 10
- Sporit GG
- Vizylac GG
- ViBact DS Capsules
- ViBact Capsules
- Unobiotics Duo
- Bifilac GG Duo
- Unobiotics SB
- Rescunate
- Colonise Forte
- Biosun Instant
- Eurobiotic Germina Capsules
- Eurobiotic Germina
- Tummy Soft Dry Syrup
- Tummysoft AD
- Tummysoft Drops
Bifilac Lozenge Manufacturer
Manufacturer
Allianz Biosciences Pvt Ltd
Minimum Order Quantity
1,25,000 Sachets
Form
Lozenge
Composition
Pre & Probiotic
Key Ingredients
Each BIFILAC Lozenge contains
- Streptococcus faecalis T-110 JPC - 30 million
- Clostridium butyricum TO-A - 2 million
- Bacillus mesentericus TO-A - 1 million
- Lactic acid bacillus (Lactobacillus sporogenes) - 50 million
Description
BIFILAC contains, Streptococcus faecalis T-110, Clostridium butyricum TO-A, Bacillus mesentericus TO-A which are patented strains, licensed from TOA Pharmaceuticals Co. ltd, Japan and Lactic acid bacillus (Lactobacillus sporogenes), which is a time tested probiotic strain. Through their symbiotic action they produce certain pathogen (Bad bacteria) inhibiting factors and in addition also produce a bifidogenic nutrient which helps in increasing the count of beneficial bacteria in the intestine.
Get more details
